Invesaro

Stocks IREN Financial statements

Financial statements

IREN Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data IREN Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2022FY2022FY2023FY2024FY2025FY2026
Revenue2.177.95975.5187501707
Cost of revenue39.487.1159220
Gross profit36.1100342487
Selling, general and administrative4970.4136449
Operating income-1.68-0.520.31-157-27.217.3-1,047
Interest expense0.161.242516.20.11159.3
Interest income0.925.837.580.6
Other non-operating income-12.21.7776.2338
Pre-tax income-2.14-59.2-417-169-25.593.5-709
Income tax01.242.722.393.456.56-6.06
Net income-2.14-60.4-420-172-28.986.9-703
EBITDA-12723.2198-629
EPS, basic-0.13-2.93-10.25-3.14-0.290.41-2.22
EPS, diluted-0.13-2.93-10.25-3.14-0.290.39-2.22
Shares, basic (weighted)54.899.6215316
Shares, diluted (weighted)54.899.6223316
Dividend per share0.000.000.000.00

Balance sheet

FY2020FY2022FY2022FY2023FY2024FY2025FY2026
Cash and equivalents1.963911068.94055655,896
Short-term investments6.530
Receivables0.151.5621
Other current assets11.920.836
Total current assets2.5740.416089.24526417,886
Property, plant and equipment8.0415.92482414411,9316,753
Lease right-of-use assets0.41.41.251.371.341.463
Goodwill0.570.660.6300036
Intangible assets0317
Long-term investments02120
Other non-current assets0.430.4959
Total assets11.61345703321,1532,94015,790
Accounts payable0.751.1218.816.627.381.71,297
Accrued liabilities4.4142.4527
Deferred revenue0.8846
Short-term debt1.967260.50.190169
Total current liabilities2.7617085.12451.11492,221
Long-term debt9637,424
Lease liabilities1.261.031.062
Other non-current liabilities0.120.238
Total liabilities2.7618413326.755.31,12311,604
Total debt83.81081.459637,593
Paid-in capital51.388.7-1,647
Retained earnings-2.25-62.6-482-654-683-596-1,299
Other comprehensive income-35-30.1-41
Shareholders' equity4373051,0971,8174,186
Total equity8.82-49.54373051,0971,8174,186
Total liabilities and equity11.61345703321,1532,94015,790

Cash flow statement

FY2020FY2022FY2022FY2023FY2024FY2025FY2026
Net income-2.14-60.4-420-172-28.986.9-703
Depreciation and amortization30.750.5181418
Stock-based compensation14.423.642.6205
Deferred income tax3.321.714.9-11.7
Change in payables-2.110.116.738
Cash from operations-0.991.76-37.55.7352.22462,100
Capital expenditures-3.91-7.3-83.7-116-142-573-2,998
Cash from investing-4.22-81.4-259-71.5-498-1,380-4,723
Debt issued017.165.200
Debt repaid0-2.12-12.1-9.4300-9.21
Stock issued2.680039.3006.6
Cash from financing6.7311837228.67831,2959,680
Exchange rate effect0.36-1.39-4.5-3.89-0.67
Net change in cash-37.23361607,057
Free cash flow-4.9-5.54-121-110-89.6-328-898
Interest paid00.335.254.10.217.6342.6
Income taxes paid01.4202.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $19.73 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin73.4%Gross profit / revenue.
Operating margin-166.4%Operating income / revenue.
EBITDA margin-97.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-222.3%Pre-tax income / revenue.
Net margin-194.3%Net income / revenue.
FCF margin-354.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin357.9%Cash from operations / revenue.
Return on equity (ROE)-26.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-6.6%Net income / average total assets.
Return on invested capital (ROIC)-8.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue75.9%Selling, general and administrative expense / revenue.
Stock-based pay / revenue34.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue712.1%Capital expenditures / revenue.
D&A / revenue69.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y41.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y110.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y145.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y42.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y138.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y-6,141.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-416.9%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-908.2%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-669.2%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y754.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y615.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y312.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y130.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y139.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y437.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y262.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y159.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y41.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y79.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.60xCurrent assets / current liabilities.
Quick ratio0.94x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.89x(Cash + short-term investments) / current liabilities.
Debt / equity1.93xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets48.0%Total debt / total assets.
Liabilities / assets75.2%Total liabilities / total assets.
Net debt$6.38BTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-9.41xOperating income / interest expense.
Working capital$2.35BCurrent assets - current liabilities.
Goodwill and intangibles / assets4.4%(Goodwill + intangible assets) / total assets.
Tangible book value$4.21BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.03xRevenue / average total assets.
Fixed asset turnover0.06xRevenue / average property, plant and equipment.
Receivables turnover3.62xRevenue / average receivables.
Days sales outstanding101 days365 x average receivables / revenue.
Days payables4,176 days365 x average accounts payable / cost of revenue.
Capex / operating cash flow199.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.39Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$1.74Revenue / diluted weighted shares.
FCF per share-$6.18Free cash flow / diluted weighted shares.
Operating cash flow per share$6.24Cash from operations / diluted weighted shares.
Book value per share$12.84Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$10.56Tangible book value / shares outstanding.
Cash per share$8.84(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$7.05BShare price x shares outstanding.
Enterprise value$13.43BMarket cap + total debt - cash - short-term investments.
P/S10.1xMarket cap / revenue.
P/B1.38xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.67xMarket cap / tangible book value, when positive.
P/OCF2.83xMarket cap / cash from operations, when positive.
EV/Sales19.3xEnterprise value / revenue.
FCF yield-34.9%Free cash flow / market cap.
Earnings yield-19.2%Net income / market cap (the inverse of P/E).
What was IREN Ltd's revenue in fiscal 2026?

IREN Ltd reported revenue of $707.0M for fiscal 2026, 41.1% higher than the year before.

Was IREN Ltd profitable in fiscal 2026?

No. It reported a net loss of $702.6M.

How much free cash flow did IREN Ltd generate in fiscal 2026?

Cash from operations of $2.10B minus capital expenditures of $3.00B left free cash flow of -$897.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to IREN Ltd